[Successful treatment of weekly paclitaxel for a patient with recurrent lung cancer].
A 44-year-old man with recurrent lung cancer was readmitted to the hospital for chemotherapy. He was first treated by chemotherapy of CDDP + etoposide, after which the chemotherapy was changed to a regimen of weekly paclitaxel because of his desire to work. He could then be discharged from the hospital and return to his work. No side effects of this frequent schedule on his immune function were noted. He is now doing well and working. The regimen of weekly paclitaxel seemed to be effective in improving QOL because that regimen allowed him to work.
Kawasaki
Yuji
Y
Dept. of Respiratory Medicine, Matsue National Hospital.
Kato
Kazuhiro
K
Kobayashi
Kanako
K
Yano
Shuuichi
S
Saito
Shinji
S
Tokushima
Takeshi
T
Miyata
Masanori
M
Matsumoto
Shingo
S
Mikami
Masaaki
M
Yasuda
Kazuhito
K
Hitsuda
Yutaka
Y
Shimizu
Eiji
E
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage*; D011788:Quality of Life
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel